3 Under-$4 Biotech Stocks With Massive Growth Prospects
While the broader market has been all over the place over the past few months, one area that has performed significantly better than the S&P…
davidgoldstein
3 “Exciting Biotech Plays That Won’t Break The Bank”
Looking for “exciting biotech plays that won’t break the bank”? Today’s article highlights three such plays, all of which are trading under $3 per share,…
Why This Biotech’s Mixed Clinical Results Shouldn’t Discourage Investors With A High Risk Tolerance
The small-cap biotech highlighted in today’s article has had mixed clinical results when it comes to one of its novel cancer immunotherapy candidates. The author,…
Swinging Opportunities In Exchange Stocks
Heightened volatility across most asset classes over the last two months has led to a surge in trading volumes – and to exchange stocks (the…
Upside Potential In The Pipelines: 3 “Strong Buy” Biotech Stocks To Consider
Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those…
Biotech’s Historic Month (And Whether It Can Last)
After three straight months of losses, April brought the S&P 500 health care sector its best one-month gain in twenty years, and today’s article notes…
More Evidence That Biotech Is The “Next Gold Mine”
If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech…
Are These Biotech And Energy Stocks The Best Penny Stock Picks Right Now?
In the world of penny stocks, biotech penny stocks and energy penny stocks have been among the big movers recently – and the author of…
3 “Compelling” Biotech Stocks With Small Price Tags And Big Upside Potential
In assessing the current market environment, the author of today’s article notes that “it becomes apparent that there’s an opportunity for those able to take…
What Are Insiders Seeing In This Clinical-Stage Biotech?
The clinical-stage biopharmaceutical company highlighted in today’s article is focused on the development of novel therapies for cardio-metabolic disease, liver disease, ophthalmic disease and cancer…